List of works - David Cameron

An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer ⬇️

scientific article published on September 18, 2012

Chemotherapy, Trastuzumab, and Pathological Complete Response: When Shall We Three Meet Again? ⬇️

scientific article published on July 25, 2011

Chromosome instability and benefit from adjuvant anthracyclines in breast cancer ⬇️

scientific article published on May 29, 2012

Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model

scientific article published on 28 February 2022

Foundation clinical trials

scientific article

Impact of Screening and Risk Factors for Local Recurrence and Survival After Conservative Surgery and Radiotherapy for Early Breast Cancer: Results From a Large Series With Long-Term Follow-Up ⬇️

scientific article published on December 22, 2011

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole ⬇️

scientific article published on October 1, 2012

In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer ⬇️

scientific article published on June 3, 2011

Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial? ⬇️

scientific article published on April 9, 2013

Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer ⬇️

scientific article published on November 17, 2003

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer

scientific article published in February 2016

Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapy ⬇️

scientific article published on January 1, 1997

Proximity ligation assays for isoform‐specific Akt activation in breast cancer identify activated Akt1 as a driver of progression ⬇️

scientific article published on April 30, 2012

Research-intensive cancer care in the NHS in the UK ⬇️

scientific article published on November 1, 2011

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer ⬇️

scientific article published on March 11, 2011

Should all adjuvant breast cancer patients receive a bisphosphonate?

scientific article

Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer

scientific article published on 20 February 2020

Strengthening clinical cancer research in the United Kingdom ⬇️

scientific article published on May 10, 2011

Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression ⬇️

scientific article published on September 1, 1997

Targeting anthracyclines in early breast cancer: new candidate predictive biomarkers emerge ⬇️

scientific article published on 02 August 2010

The Royal College of Physicians Simms Lecture, 6 December 2011: Clinical research networks and the benefits of intensive healthcare systems ⬇️